Jana G Hashash, MD, MSc

Stem Cell Transplants for Crohn’s disease @MayoClinic Incredibly thankful for our patients for their trust - below you can listen to Amy’s story! youtu.be/SBB0rJ_zsxQ #ErnestoAyala @MadihaIqbal13 @MKD_BMT @ibdgijami @AmerGastroAssn @AmCollegeGastro @CrohnsColitisFn

A Joint @RomeFoundation and @IOIBD1 Consensus provides standardized terminology, evaluation strategies, and treatment recommendations for #IBD with #IBS-like symptoms 🔖 in @AGA_Gastro 👉 doi.org/10.1053/j.gast…

We’re your GI home throughout fellowship and beyond! Unlock more resources, and education to support your GI career by joining AGA for free as a first-year trainee. Apply here: gastro.org/membership/ben….

@dr_fcalderaibd @uwsmph @uw_medicine @uw_GIHep Congrats @dr_fcalderaibd — so well deserved!

1/ Big month. Yesterday I had the honor of being invested as the Yehle Family Professor in IBD Research at @uwsmph alongside being promoted to Professor of Medicine. A surreal night, still sinking in. A short thread on what it means. @uw_medicine @uw_GIHep

📣 #CC360 has ⬆️ its 2025 impact factor to 3🏆 🥳Congrats authors, AEs & @CrohnsColitisFn for advancing high quality #MedEd & #IBD care 💻 Submit your manuscript for an impactful 🌎 reach 📲If interested to be an AE (adult & peds IBD, surgery, GastroPsych, PharmD, GastroRD)

If you missed my debate with #DrSiegel on using anti-TNF vs anti-IL23 for #CD in pts with #cancer @CrohnsColitisFn, do not worry as @gastroendonews highlights 🔑 points below👇 👉 reference: AGA CPU which I coauthored with @DrJordanAxelrad @AGA_CGH pubmed.ncbi.nlm.nih.gov/38752967/

@JHashashMD @MayoFL_IMRES @MayoGIMFL @HSaleh_MD @MarisaZayatMD @MaryHedgesMD @aelsab @passisd @JessPetrovMD @FarrayeIBD @ibdgijami Of course !!! You are an amazing teacher and educator !! Congratulations @JHashashMD thank you for all the work you do to shape the next gen of GI stars !

@JHashashMD @MayoFL_IMRES @MayoGIMFL @HSaleh_MD @MarisaZayatMD @MaryHedgesMD @aelsab @passisd @JessPetrovMD @FarrayeIBD @ibdgijami You’re my Top Teacher too 😍📚

Incredibly humbled to receive one of the 2026 🏆 Top Teacher Awards🏅from the Internal Medicine Residents 👩‍⚕️👨‍⚕️🩺 @mayofl_imres @MayoGIMFL

@IBDimmunology @MondayNightIBD @vipuljairath @DCharabaty @SanofiUS @IBD_Houston @ibdtweets @BattatMD4IBD @NarulaNeeraj @guthealthmd @P_DeepakIBDMD @ibdseb @ShomronH @waqqasafif Depends on what happened with IFX previously — did pt develop anti-drug Abs? How long ago was IFX used? Why was it d/ced? If IFX wasn’t given a good enough chance, I’d go with option 2 (specifically 10mg/kg of ifx with gus)

@vipuljairath @DCharabaty @MondayNightIBD @SanofiUS @IBD_Houston @ibdtweets @BattatMD4IBD @NarulaNeeraj @guthealthmd @P_DeepakIBDMD @ibdseb @ShomronH Ok let’s make this interesting @waqqasafif - what DTT would you go with (assume no restrictions) 1. IFX + Risa 2. IFX + Gus 3. Goli + Gus Yes. I disrespect you Cimzia.

What’s next in terms of therapeutic options in a patient with refractory #IBD Join the convo with @vipuljairath @DCharabaty 🗳️ (polls are still glitching but 🤞🏼) & share your thoughts 💬 with us ! Supported by educational grants @SanofiUS

Patients with #IBD involving the colon face an 8️⃣x greater risk of #CDiff infection than the general population. Read more: ow.ly/63bO50ZabPW

MUST READ📖 Joint @RomeFoundation & @IOIBD1 RAND/UCLA Recommendations for #Evaluation & #Managmt of #IBD with #IBS-like Symptoms @AGA_Gastro pubmed.ncbi.nlm.nih.gov/42066865/ 📝Nomenclature: IBD with IBS-like symptoms Evaluation🩺 🧫 Therapies 🥗Diet 💊Drugs💉 🧠Brain gut behavioral tx

🚨 New Publication! 🚨 Excited to share our new article in @JCGjournal: “Comparison of Ustekinumab and Vedolizumab Effectiveness in Perianal Crohn’s Disease” Our findings suggest a potential effectiveness benefit of UST over VZD in patients with PCD, with lower rates of fistula-related surgery and antibiotic use. @JHashashMD @FarrayeIBD @OmarMTag @jensemineriomd 👉 Read the article here: doi.org/10.1097/mcg.00…

Congratulations @EileenMOReilly @MSKCancerCenter @MSK_DeptOfMed Brian Wolpin Ziv Wainberg and all colleagues on a long awaited and badly needed game changer in #pancreascancer

Great summary from @AmerGastroAssn on #IBD and #IBDmedications related #cancers 👉 cghjournal.org/article/S1542-…

Bowel urgency #BU 😖🚽💩is an under recognized debilitating symptom amongst patients with IBD 📻Tune in tomorrow for @AmCollegeGastro virtual grand rounds for a presentation on #BU moderated 👨‍⚖️ by @ibdtweets ➡️ gi.org/education/acg-…

Feeling very grateful to see our study featured in GI & Hepatology News 🙏 This work would not have been possible without the kindness, mentorship, and support of @Alomari_MD , @AsadurRahman87 , @JHashashMD . Truly thankful to learn from such wonderful mentors along the way 🤍

🫵 Have you been asked by a patient with Crohn's or Ulcerative Colitis what they could to change their diet or what complementary medicine can be considered to help manage their IBD? ➡️ Then look no further, and 🏃‍♂️‍➡️ check out this new review on this topic❗ 🔗 bit.ly/4deeSGJ Salvatore Crucillà Fadi H Mourad @JHashashMD @PhilSmithIsBack @OTavabie @dr_aditi_kumar @TrevorTabone @eathar_s @IrenePerezMD @KGananandan @zare_benjamin @medicalreg @dtleiberman @BASLedu @BSGtrainees @ulstergastro #GITwitter #GIX

‼️Don’t miss the @AmerGastroAssn 🏋️‍♀️Battle of the Heavyweights 🏋️‍♂️ @DDWMeeting this year‼️ 🌟 Authors will debate hot 🔥 topics from recent #CPUs 📝 in @AGA_Gastro & @AGA_CGH 🗓️Monday, May 4 ⏰2.00-3.30pm CT 📍McCormick Place Convention Center 👩‍⚖️@SultanShazi and @JHashashMD

📣Calling all GI dietitians! Join us and #DIGID for a meetup at #DDW2026! 🥕🍎 Add this date your DDW calendar ⬇️ 📅 Monday, May, 4, 1 p.m. 📍 AGA Central (West Central Concourse, Level 3) ow.ly/x9jN50YK6aT